BR112019010636A2 - ensaios com anticorpos - Google Patents
ensaios com anticorpos Download PDFInfo
- Publication number
- BR112019010636A2 BR112019010636A2 BR112019010636-7A BR112019010636A BR112019010636A2 BR 112019010636 A2 BR112019010636 A2 BR 112019010636A2 BR 112019010636 A BR112019010636 A BR 112019010636A BR 112019010636 A2 BR112019010636 A2 BR 112019010636A2
- Authority
- BR
- Brazil
- Prior art keywords
- tumor marker
- panel
- epcam
- aif1
- mmp9
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Gastroenterology & Hepatology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1619954.9 | 2016-11-25 | ||
| GBGB1619954.9A GB201619954D0 (en) | 2016-11-25 | 2016-11-25 | Antibody assay |
| PCT/GB2017/053541 WO2018096351A1 (en) | 2016-11-25 | 2017-11-24 | Antibody assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019010636A2 true BR112019010636A2 (pt) | 2019-10-01 |
Family
ID=58073509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019010636-7A BR112019010636A2 (pt) | 2016-11-25 | 2017-11-24 | ensaios com anticorpos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20190376975A1 (https=) |
| EP (1) | EP3545309B1 (https=) |
| JP (1) | JP7249284B2 (https=) |
| KR (1) | KR20190088510A (https=) |
| CN (2) | CN108107218B (https=) |
| AU (1) | AU2017365931A1 (https=) |
| BR (1) | BR112019010636A2 (https=) |
| CA (1) | CA3044492A1 (https=) |
| GB (1) | GB201619954D0 (https=) |
| IL (1) | IL266857A (https=) |
| MX (1) | MX2019006098A (https=) |
| RU (1) | RU2769987C2 (https=) |
| WO (1) | WO2018096351A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109116023B (zh) * | 2018-06-14 | 2021-06-04 | 郑州大学第一附属医院 | 一种肺癌标志物抗-mmp12自身抗体及其应用 |
| CN109709335B (zh) * | 2018-12-18 | 2020-10-27 | 中国医学科学院基础医学研究所 | 热休克蛋白hspa4在肿瘤转移预测、预后评估和治疗中的应用 |
| CN109633165B (zh) * | 2018-12-18 | 2021-03-09 | 中国医学科学院基础医学研究所 | 抗hspa4自身抗体作为乳腺癌诊断或预后评估标志物的应用 |
| ES3039706T3 (en) * | 2019-02-19 | 2025-10-24 | Otsuka Denshi Kk | Method for determining condition parameters for photodynamic therapy and photodynamic therapy apparatus |
| CN110579611B (zh) * | 2019-09-18 | 2023-01-31 | 郑州大学 | 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法 |
| JPWO2022118947A1 (https=) * | 2020-12-04 | 2022-06-09 | ||
| CN114994318A (zh) * | 2022-06-16 | 2022-09-02 | 深圳上泰生物工程有限公司 | 一种用于检测akr1b10的试剂盒及其制备方法 |
| CN116444680B (zh) * | 2022-12-28 | 2024-05-03 | 杭州凯保罗生物科技有限公司 | 一种ralgds-krt8-aif1融合肿瘤抗原蛋白的制备方法及其应用 |
| CN119639903B (zh) * | 2025-01-17 | 2025-11-25 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 用于肝内胆管癌的生物标记物、药物及其应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7387881B2 (en) * | 2001-09-19 | 2008-06-17 | The Regents Of The University Of Michigan | Detection and treatment of cancers of the liver |
| ITPD20030264A1 (it) * | 2003-10-30 | 2005-04-30 | Xeptagen Spa | Metodo di diagnosi altamente specifico per neoplasie |
| TWI281473B (en) * | 2003-12-19 | 2007-05-21 | Ind Tech Res Inst | Biomarkers for liver diseases and method for using same |
| CN1632589A (zh) * | 2003-12-24 | 2005-06-29 | 财团法人工业技术研究院 | 肝脏疾病的生物标记分子及其检测方法 |
| US20080254481A1 (en) * | 2006-11-13 | 2008-10-16 | Invitrogen Corporation | Methods and kits for detecting prostate cancer biomarkers |
| CN102301237B (zh) * | 2008-12-02 | 2014-05-14 | 财团法人工业技术研究院 | 用于肝纤维化诊断的生物标记 |
| CN102356316B (zh) * | 2009-03-05 | 2015-07-08 | 独立行政法人产业技术综合研究所 | 肝内胆管癌的检出、辨别方法 |
| US20120309034A1 (en) * | 2010-02-12 | 2012-12-06 | Nitto Boseki Co., Ltd. | METHOD FOR MEASURING IMMUNITY OF COMPLEX OF Ku86 AND AUTOANTIBODY THEREOF, KIT USED THEREFOR, AND METHOD FOR DETERMINING CANCER USING SAME |
| CN102175864A (zh) * | 2011-01-19 | 2011-09-07 | 江苏永鼎股份有限公司 | 一组早期肝癌分子标志物及其应用 |
| CN102507938B (zh) * | 2011-10-08 | 2014-12-24 | 复旦大学附属中山医院 | 一种肝癌转移预测定量抗体芯片及试剂盒 |
| US20150185226A1 (en) * | 2012-07-23 | 2015-07-02 | Inserm (Institut National De La Sante Et La Recherche Medicale) | Method for Diagnosing Scleroderma |
| JP2014240771A (ja) * | 2013-06-11 | 2014-12-25 | 日東紡績株式会社 | Ｋｕ７０／Ｋｕ８６ヘテロダイマーに対する自己抗体の免疫測定方法、それに用いるキットおよびそれを用いた癌判定方法 |
| GB201320061D0 (en) * | 2013-11-13 | 2013-12-25 | Electrophoretics Ltd | Materials nad methods for diagnosis and prognosis of liver cancer |
| GB201411060D0 (en) * | 2014-06-20 | 2014-08-06 | Oncimmune Ltd | Improved immunoassay method |
| TWI700493B (zh) * | 2014-07-02 | 2020-08-01 | 香港商龍勝發展有限公司 | 用於非侵入性肝癌診斷之特異性生物標記組 |
| CN104990905B (zh) * | 2015-06-30 | 2017-12-29 | 曲凯 | 一种基于固相酶联免疫荧光斑点的肝癌转移诊断试剂盒 |
-
2016
- 2016-11-25 GB GBGB1619954.9A patent/GB201619954D0/en not_active Ceased
-
2017
- 2017-11-24 WO PCT/GB2017/053541 patent/WO2018096351A1/en not_active Ceased
- 2017-11-24 JP JP2019548777A patent/JP7249284B2/ja active Active
- 2017-11-24 EP EP17807913.3A patent/EP3545309B1/en active Active
- 2017-11-24 CA CA3044492A patent/CA3044492A1/en not_active Abandoned
- 2017-11-24 AU AU2017365931A patent/AU2017365931A1/en not_active Abandoned
- 2017-11-24 US US16/463,549 patent/US20190376975A1/en active Pending
- 2017-11-24 RU RU2019118625A patent/RU2769987C2/ru active
- 2017-11-24 MX MX2019006098A patent/MX2019006098A/es unknown
- 2017-11-24 KR KR1020197018129A patent/KR20190088510A/ko not_active Withdrawn
- 2017-11-24 BR BR112019010636-7A patent/BR112019010636A2/pt active IP Right Grant
- 2017-11-27 CN CN201711213227.4A patent/CN108107218B/zh active Active
- 2017-11-27 CN CN202110715736.7A patent/CN113655224A/zh active Pending
-
2019
- 2019-05-23 IL IL266857A patent/IL266857A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN108107218B (zh) | 2021-10-08 |
| JP7249284B2 (ja) | 2023-03-30 |
| WO2018096351A1 (en) | 2018-05-31 |
| CN108107218A (zh) | 2018-06-01 |
| JP2020515826A (ja) | 2020-05-28 |
| RU2019118625A3 (https=) | 2021-03-31 |
| CA3044492A1 (en) | 2018-05-31 |
| EP3545309A1 (en) | 2019-10-02 |
| AU2017365931A1 (en) | 2019-06-06 |
| RU2019118625A (ru) | 2020-12-25 |
| GB201619954D0 (en) | 2017-01-11 |
| US20190376975A1 (en) | 2019-12-12 |
| KR20190088510A (ko) | 2019-07-26 |
| IL266857A (en) | 2019-07-31 |
| MX2019006098A (es) | 2019-12-02 |
| RU2769987C2 (ru) | 2022-04-12 |
| EP3545309B1 (en) | 2021-03-31 |
| CN113655224A (zh) | 2021-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112019010636A2 (pt) | ensaios com anticorpos | |
| RU2416095C2 (ru) | Улучшенные способы иммуноанализа | |
| US20120100558A1 (en) | Lung cancer diagnosis | |
| CN106662586A (zh) | 改进的免疫测定方法 | |
| CN103547923A (zh) | 乳腺癌的生物标记 | |
| Fan et al. | Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of colorectal cancer | |
| WO2010136629A1 (es) | Métodos para el diagnóstico o pronóstico del cáncer colorrectal | |
| NO341484B1 (no) | Forbedrede immunoassay metoder | |
| CA2799359C (en) | Method for the diagnosis/prognosis of colorectal cancer | |
| JP7744641B2 (ja) | 肺癌における自己抗体を検出するための抗原の組合せの使用 | |
| US8697368B2 (en) | Diagnostic marker for lung cancer comprising HPαR as active ingredient | |
| EP3438669A1 (en) | Method for determining susceptibility to diabetes | |
| TW201928351A (zh) | 抗體測定 | |
| US20230375550A1 (en) | Method for diagnosing breast cancer by using biomarker | |
| GB2600701A (en) | Antibody assay |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: ONCIMMUNE LIMITED (GB) Free format text: A FIM DE ATENDER A ALTERACAO DE SEDE E DE NOME REQUERIDAS ATRAVES DA PETICAO NO 870250053805 DE 26/06/2025, E NECESSARIO APRESENTAR UMA PETICAO PARA CADA SOLICITACAO FEITA, UMA VEZ QUE DESDE A PORTARIA 20/2024 NAO E MAIS PERMITIDO SOLICITAR MAIS DE UM SERVICO POR PETICAO. ALEM DISSO, E PRECISO APRESENTAR A GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
| B25E | Requested change of name of applicant rejected |
Owner name: ONCIMMUNE LIMITED (GB) Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 870250053805 DE 26/06/2025, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2853, DE 09/09/2025. |
|
| B25D | Requested change of name of applicant approved |
Owner name: FREENOME LIMITED (GB) |
|
| B25G | Requested change of headquarter approved |
Owner name: FREENOME LIMITED (GB) |
|
| B25E | Requested change of name of applicant rejected |
Owner name: FREENOME LIMITED (GB) Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 870250081308 DE 10/09/2025, EM VIRTUDE DA DOCUMENTACAO QUE FOI APRESENTADA NA PETICAO NAO SER REFERENTE A ESSE PEDIDO. |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/11/2017, OBSERVADAS AS CONDICOES LEGAIS |